MedPath

INTEGRATIVE PHENOMICS

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk

Not yet recruiting
Conditions
Risk Factor, Cardiovascular
Low-grade Inflammation
Overweight
Obesity
Metabolic Syndrome
Healthy
Hypertension
Metabolically Healthy Controls
Normal Weight Adults
Hypercholesterolemia
First Posted Date
2024-04-09
Last Posted Date
2024-04-09
Lead Sponsor
Integrative Phenomics
Target Recruit Count
3000
Registration Number
NCT06355544

Study of the Intestinal Microbiota During a Real Life Dietary Intervention in Subjects With Overweight or Obesity

Completed
Conditions
Overweight and Obesity
First Posted Date
2021-03-30
Last Posted Date
2021-04-08
Lead Sponsor
Integrative Phenomics
Target Recruit Count
1855
Registration Number
NCT04822948
Locations
🇫🇷

RNPC, Marseille, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.